In the April–June 2018 edition of Corporate Disputes, Dr. Gregory K. Bell discusses recent litigation involving companies operating in the pharmaceutical and medical device sector and the factors driving them. In this roundtable discussion, the panel experts explain the main issues and challenges these types of companies face during the litigation process. To read the article, click the download button to the right.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...